Daejeon, South Korea

Yu Na Lim

This inventor holds 1 USPTO granted patent and 16 published patent applications and 1 EPO patent. Top assignee: Biorchestra Co., Ltd.. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Yu Na Lim in Micellar Nanoparticles

Introduction

Yu Na Lim is an accomplished inventor based in Daejeon, South Korea. He has made significant contributions to the field of nanotechnology, particularly in the development of micellar nanoparticles. His innovative work focuses on creating effective drug delivery systems that can enhance therapeutic outcomes.

Latest Patents

Yu Na Lim holds a patent for "Micellar nanoparticles and uses thereof." This patent describes cationic carrier units that include a water-soluble polymer, a positively charged carrier, and an adjuvant moiety. When mixed with an anionic payload, such as an antisense oligonucleotide, these carrier units self-organize into a micelle that encapsulates the anionic payload in its core. The technology also allows for the inclusion of a tissue-specific targeting moiety on the micelle's surface, enhancing its effectiveness in treating various diseases.

Career Highlights

Throughout his career, Yu Na Lim has demonstrated a strong commitment to advancing medical technology. His work at Biorchestra Co., Ltd. has positioned him as a key player in the development of innovative pharmaceutical solutions. His research has the potential to significantly impact the treatment of various medical conditions.

Collaborations

Yu Na Lim collaborates with talented individuals such as Jin-Hyeob Ryu and Hyun Su Min. These partnerships foster a creative environment that drives innovation and enhances the development of new technologies.

Conclusion

In summary, Yu Na Lim's contributions to the field of micellar nanoparticles represent a significant advancement in drug delivery systems. His innovative approach and dedication to research continue to pave the way for future breakthroughs in medical technology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…